Sign in

CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880378336
Phone
(646) 677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. SC 13G Stake Amended Statement of Ownership
  2. 4 Open-market sale 10% owner sold 192,927 shares at an average $1.83 ($352,372)
  3. 4 Open-market sale 10% owner sold 50,000 shares at an average $1.71 ($85,495)
  4. 4 Open-market sale 10% owner sold 9,468 shares at an average $1.72 ($16,287)
  5. 8-K Event Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 4 Open-market sale 10% owner sold 3,100 shares at an average $1.80 ($5,581)
  8. 4 Open-market sale 10% owner sold 21,990 shares at $1.80 ($39,582)
  9. 4 Open-market sale 10% owner sold 20,840 shares at an average $1.81 ($37,762)
  10. 4 Open-market sale 10% owner sold 148,100 shares at an average $1.81 ($268,436)
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Open-market sale 10% owner sold 33,619 shares at $1.90 ($63,876)
  13. 4 Open-market sale 10% owner sold 17,790 shares at an average $2.01 ($35,716)
  14. 4 Open-market sale 10% owner sold 169,450 shares at an average $1.97 ($333,385)
  15. 4 Open-market sale 10% owner sold 40,068 shares at an average $1.92 ($77,061)
  16. 4 Open-market sale 10% owner sold 36,400 shares at an average $1.90 ($69,236)
  17. 10-Q Report Quarterly Report
  18. 4 Open-market sale 10% owner sold 52,577 shares at an average $2.04 ($107,265)
  19. 4 Open-market sale 10% owner sold 196,497 shares at an average $2.03 ($398,919)
  20. SC 13D/A Stake Beneficial Ownership Report

Page 16 of 26 · 511 filings